Listing #2036587 oncnursingnews.com
334
The FDA granted a priority review for a Biologics License Application (BLA) to
bastilimab for the treatment of recurrent or metastatic cervical cancer. Cancer ...
Category
Website Performance
| firstMeaningfulPaint | 2.31 Sec |
| observedLoad | 1.8 Sec |
| observedTraceEndTs | 505390616381 |
| observedCumulativeLayoutShift | 0 Sec |
| observedFirstContentfulPaintAllFrames | 0.3 Sec |
| observedFirstVisualChangeTs | 505383700351 |
| observedLargestContentfulPaint | 1.13 Sec |
| cumulativeLayoutShiftMainFrame | 0 Sec |
| observedNavigationStartTs | 505383227351 |
| observedLoadTs | 505385029834 |
| observedSpeedIndex | 2.05 Sec |
| observedSpeedIndexTs | 505385273780 |
| observedFirstContentfulPaint | 0.3 Sec |
| observedFirstMeaningfulPaint | 1.13 Sec |
| observedTimeOriginTs | 505383227351 |
| totalCumulativeLayoutShift | 0 Sec |
| interactive | 6.99 Sec |
| largestContentfulPaint | 4.57 Sec |
| observedTraceEnd | 7.39 Sec |
| observedCumulativeLayoutShiftMainFrame | 0 Sec |
| observedTimeOrigin | 0 Sec |
| observedLargestContentfulPaintTs | 505384353002 |
| cumulativeLayoutShift | 0 Sec |
| observedLargestContentfulPaintAllFrames | 1.13 Sec |
| observedFirstContentfulPaintTs | 505383529513 |
| observedTotalCumulativeLayoutShift | 0 Sec |
| speedIndex | 3.5 Sec |
| observedFirstContentfulPaintAllFramesTs | 505383529513 |
| totalBlockingTime | 0.39 Sec |
| observedFirstPaintTs | 505383529513 |
| observedFirstPaint | 0.3 Sec |
| observedLastVisualChangeTs | 505388399351 |
| observedNavigationStart | 0 Sec |
| firstContentfulPaint | 1.27 Sec |
| observedDomContentLoadedTs | 505383421093 |
| maxPotentialFID | 0.19 Sec |
| observedLastVisualChange | 5.17 Sec |
| observedLargestContentfulPaintAllFramesTs | 505384353002 |
| observedFirstVisualChange | 0.47 Sec |
| observedDomContentLoaded | 0.19 Sec |
| observedFirstMeaningfulPaintTs | 505384353002 |
